The Master of Biomedical Innovation (MBI) program is a multidisciplinary, project-oriented graduate program focused on bridging the gap between technology development and its transfer into local, national, and international biomedical markets.
By linking the theory and practice of the biomedical innovation process, the program delivers a systematic but responsive approach to the critical, emerging discipline of innovation and entrepreneurship (I&E).
Admissions for the 2025/2026 academic year are now closed
You will learn how to create and market biomedical products or devices.
You will network and learn from renowned inventors and innovators.
You will better understand emerging opportunities in therapeutics, artificial intelligence (AI), medtech,
and more.
The MBI is a one-year program with the curriculum divided into three phases guiding learners through the
biomedical innovation and entrepreneurship process.
Information Box Group
Term 1 - Biomedical problem identification and exploration
Term 2 - Solutions design and prototyping
